Detalhe da pesquisa
1.
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
N Engl J Med
; 386(9): 847-860, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139271
2.
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Lancet
; 392(10143): 232-243, 2018 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30047376
3.
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.
N Engl J Med
; 374(22): 2120-30, 2016 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27192360
4.
Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial.
J Infect Dis
; 217(8): 1280-1288, 2018 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325070
5.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Ann Intern Med
; 164(5): 313-22, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26833336
6.
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
J Infect Dis
; 213(4): 541-50, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26475930
7.
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.
J Infect Dis
; 211(4): 518-28, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25165165
8.
HIV Sexual Risk and Syndemics among Women in Three Urban Areas in the United States: Analysis from HVTN 906.
J Urban Health
; 92(3): 572-83, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25743100
9.
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).
J Infect Dis
; 210(7): 1052-61, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24719474
10.
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).
J Infect Dis
; 207(2): 240-7, 2013 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23125444
11.
A HIV-1 Gp41 Peptide-Liposome Vaccine Elicits Neutralizing Epitope-Targeted Antibody Responses in Healthy Individuals.
medRxiv
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562833
12.
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Nat Commun
; 15(1): 2175, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467646
13.
Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials.
AIDS Behav
; 17(2): 760-72, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23090677
14.
Recruitment of Caribbean female commercial sex workers at high risk of HIV infection.
Rev Panam Salud Publica
; 34(2): 92-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24096973
15.
Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01.
Nat Commun
; 14(1): 7813, 2023 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016958
16.
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.
Res Sq
; 2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398105
17.
Robust antibody and cellular responses induced by DNA-only vaccination for HIV.
JCI Insight
; 5(13)2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437332
18.
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults.
Vaccines (Basel)
; 8(4)2020 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33297341
19.
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.
J Clin Invest
; 129(11): 4769-4785, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31566579
20.
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.
Sci Transl Med
; 11(510)2019 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31534016